Literature DB >> 23018094

Identification of a 2-phenyl-substituted octahydrobenzo[f]quinoline as a dopamine D₃ receptor-selective full agonist ligand.

Alia H Clark1, John D McCorvy, Jason M Conley, Whitney K Williams, Markondaiah Bekkam, Val J Watts, David E Nichols.   

Abstract

This work describes the identification of a novel class of octahydrobenzo[f]quinolines as n class="Chemical">dopamine D(3)-selective full agonists. We developed a facile method that utilizes Suzuki coupling for easy incorporations of various substituted pendant rings into the scaffold. A small focused library of octahydrobenzo[f]quinolines 5 was synthesized, and these compounds demonstrated at least 14-fold D(2)-like selectivity over D(1) in native porcine striatal tissue. Furthermore, n-propyl analog 5f was found to be a high affinity (K(i)=1.1 nM) D(3) dopamine full agonist with 145-fold selectivity over the D(2) receptor and about 840-fold selectivity over the D(1) receptor.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23018094      PMCID: PMC3505999          DOI: 10.1016/j.bmc.2012.08.058

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  22 in total

Review 1.  D1 dopamine receptors.

Authors:  X Huang; C P Lawler; M M Lewis; D E Nichols; R B Mailman
Journal:  Int Rev Neurobiol       Date:  2001       Impact factor: 3.230

2.  Discovery of β-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy.

Authors:  John A Allen; Julianne M Yost; Vincent Setola; Xin Chen; Maria F Sassano; Meng Chen; Sean Peterson; Prem N Yadav; Xi-ping Huang; Bo Feng; Niels H Jensen; Xin Che; Xu Bai; Stephen V Frye; William C Wetsel; Marc G Caron; Jonathan A Javitch; Bryan L Roth; Jian Jin
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-24       Impact factor: 11.205

Review 3.  Dopamine receptors: from structure to function.

Authors:  C Missale; S R Nash; S W Robinson; M Jaber; M G Caron
Journal:  Physiol Rev       Date:  1998-01       Impact factor: 37.312

Review 4.  The dopamine hypothesis of schizophrenia: a review.

Authors:  H Y Meltzer; S M Stahl
Journal:  Schizophr Bull       Date:  1976       Impact factor: 9.306

5.  Congeners of the alpha conformer of dopamine derived from octahydrobenz[h]isoquinoline.

Authors:  J G Cannon; T Lee; F L Hsu; J P Long; J R Flynn
Journal:  J Med Chem       Date:  1980-05       Impact factor: 7.446

6.  Monomethyl ether derivatives of 7,8-dihydroxy- and 8,9-dihydroxy-4-n-propyl-1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolines as possible products of metabolism by catechol-O-methyltransferase.

Authors:  J G Cannon; K A Walker; A Montanari; J P Long; J R Flynn
Journal:  J Med Chem       Date:  1990-07       Impact factor: 7.446

7.  Effect of beta-alkyl substitution on D-1 dopamine agonist activity: absolute configuration of beta-methyldopamine.

Authors:  R M Riggs; A T McKenzie; S R Byrn; D E Nichols; M M Foreman; L L Truex
Journal:  J Med Chem       Date:  1987-10       Impact factor: 7.446

8.  9-Dihydroxy-2,3,7,11b-tetrahydro-1H-naph[1,2,3-de]isoquinoline: a potent full dopamine D1 agonist containing a rigid-beta-phenyldopamine pharmacophore.

Authors:  D Ghosh; S E Snyder; V J Watts; R B Mailman; D E Nichols
Journal:  J Med Chem       Date:  1996-01-19       Impact factor: 7.446

9.  Specific dopamine D-1 and DA1 properties of 4-(mono- and -dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinoline and its tetrahydrothieno[2,3-c]pyridine analogue.

Authors:  R M Riggs; D E Nichols; M M Foreman; L L Truex; D Glock; J D Kohli
Journal:  J Med Chem       Date:  1987-08       Impact factor: 7.446

10.  trans-10,11-dihydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine: a highly potent selective dopamine D1 full agonist.

Authors:  W K Brewster; D E Nichols; R M Riggs; D M Mottola; T W Lovenberg; M H Lewis; R B Mailman
Journal:  J Med Chem       Date:  1990-06       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.